Blood tests could reveal hidden clues about brain injury severity

NCT ID NCT07292766

Recruiting now Knowledge-focused Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at small molecules in the blood (metabolites) of people with severe traumatic brain injury compared to those with other injuries. Researchers aim to find differences that could help determine how serious a brain injury is and predict recovery. The study involves 60 adults and uses blood samples analyzed with advanced technology.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could lead to better ways to assess the severity of traumatic brain injury and predict patient outcomes.
What could go wrong: This is an early observational study with only 60 participants, so findings may not apply broadly. It aims to gather knowledge, not test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRAUMATIC BRAIN INJURY TRAUMATIC BRAIN INJURY (TBI) PATIENTS

Contacts and locations

Locations

Aksaray University
RECRUITING

Aksaray, Ankara, 06810, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.